Advanced company searchLink opens in new window

ANASTASIS BIOTEC LIMITED

Company number 10502511

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 Mar 2024 AP01 Appointment of Dr Christina Andrea Kousparou as a director on 6 February 2024
22 Feb 2024 SH01 Statement of capital following an allotment of shares on 2 February 2024
  • GBP 33,308.17
27 Dec 2023 SH01 Statement of capital following an allotment of shares on 31 October 2023
  • GBP 33,283.06
13 Nov 2023 CS01 Confirmation statement made on 7 November 2023 with updates
07 Nov 2023 SH01 Statement of capital following an allotment of shares on 12 September 2023
  • GBP 33,170.56
07 Nov 2023 SH01 Statement of capital following an allotment of shares on 12 September 2023
  • GBP 33,170.56
07 Nov 2023 SH01 Statement of capital following an allotment of shares on 7 September 2023
  • GBP 33,155.88
07 Nov 2023 SH01 Statement of capital following an allotment of shares on 26 September 2023
  • GBP 33,227.47
07 Nov 2023 SH01 Statement of capital following an allotment of shares on 12 September 2023
  • GBP 33,170.56
07 Nov 2023 SH01 Statement of capital following an allotment of shares on 14 September 2023
  • GBP 33,171.33
25 Sep 2023 AA Total exemption full accounts made up to 31 December 2022
14 Sep 2023 SH01 Statement of capital following an allotment of shares on 5 September 2023
  • GBP 33,125.12
06 Apr 2023 TM01 Termination of appointment of Laurence John Cohen as a director on 6 April 2023
06 Apr 2023 TM01 Termination of appointment of Paul Branthwaite as a director on 6 April 2023
02 Jan 2023 CS01 Confirmation statement made on 31 December 2022 with no updates
23 Sep 2022 AA Total exemption full accounts made up to 31 December 2021
11 Apr 2022 AP01 Appointment of Mr Paul Branthwaite as a director on 8 April 2022
02 Jan 2022 CS01 Confirmation statement made on 31 December 2021 with no updates
10 Aug 2021 AA Unaudited abridged accounts made up to 31 December 2020
17 Jan 2021 CS01 Confirmation statement made on 31 December 2020 with updates
05 Nov 2020 AA Unaudited abridged accounts made up to 31 December 2019
28 Oct 2020 SH01 Statement of capital following an allotment of shares on 27 October 2020
  • GBP 32,229.3
29 Sep 2020 MA Memorandum and Articles of Association
29 Sep 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
29 Jul 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Increase auth cap 01/07/2020
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities